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Abstract 
To fulfill the Master of Public Health degree requirements from the University of San Francisco, 
I have inserted myself in the role of an intern at the Cancer Prevention Institute of California 
(CPIC). There, I completed 300 fieldwork hours on a research study called the LEGACY Girls 
Hormone Pilot Study. This pilot study seeks to gather preliminary data on urinary hormones 
steroids in developing girls and assess the feasibility of multiple urine samplings across 
menstrual cycles. Results will assist in planning a future prospective study in a large cohort of 
girls and to support a R01 grant seeking to address questions related to ovarian hormone during 
pubertal development and breast cancer risk. This fieldwork summary will include background 
on breast cancer risk factors including literature on hormones and risks factors of breast cancer, a 
description of the agency, an overview of the pilot study, and implications for breast cancer 
prevention. This paper will also provide evidence on how my fieldwork had contributed to my 
successful fulfillment of the MPH program competencies, core knowledge areas, and cross-
cutting interdisciplinary competencies of public health. Overall, this invaluable experience have 
deepened my appreciation for the field of epidemiology as it relates to cancer prevention 
research and enhanced my understanding on the inner workings of a research study.  
 Keywords: Cancer prevention, breast cancer, hormones, public health, research, 
developing girls, risk assessments  
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The LEGACY Girls Hormone Pilot Study:  
Implications for Breast Cancer Prevention through Exploring 
 Hormone Biomarkers in Young Girls  
Introduction  
In 2014, an estimated 232,670 new cases of invasive breast cancer will be diagnosed in 
the United States with 40,000 resulting in death (American Cancer Society, 2014). Breast cancer 
is the leading cause of death in women between the ages of 20 and 59 and the most common risk 
factors are being female and aging (Komen, 2014; Siegel et al., 2014). The Center for Disease 
Control and Prevention (CDC) reported that although the mortality rate of breast cancer has 
decreased drastically over the years due to advancement in treatment, early intervention efforts 
such as screening, health education, and research, breast cancer incidence rate have remained 
relatively stagnant (Edwards et al., 2013). Research on breast cancer generally seeks to enhance 
our understanding of the causes or etiology, treatment, and prevention of the disease. Although 
extensive studies on breast cancer have been employed over the years, the causes of breast 
cancer are still not fully understood which hampers our ability to prevent it.  
Most studies on breast cancer primarily focus on adult populations studying women who 
have already developed breast cancer. In recent years, more progressive studies have 
increasingly sought to examine risks factors in younger populations by exploring measures of 
growth and development in children and adolescence and assessing risks factors associated with 
breast cancer (i.e. Wolff, et al., 2010; Bodicoat, et al., 2014; Biro, et al., 2013). In a report by Dr. 
Sandra Steingraber for the Breast Cancer Fund, a non-profit organization dedicated to breast 
cancer prevention, she indicates that there is an alarming trend of early pubertal development in 
girls in the United States (Steingraber, 2007). More startling is that early puberty in girls is 
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associated with a number of health problems in girls that persist later on in life. Early onset of 
menarche, for example, is now a well-established risk factor for breast cancer (Apter & Vikho, 
1983; Kelsey, Gammon, & John, 1993; Collaborate Group on Hormonal Factors in Breast 
Cancer, 2012). Furthermore, retrospective studies on breast cancer patients have also supported 
findings on the adverse effects of early puberty. High levels of estrogen estradiol in the blood 
have been linked to increased breast cancer risk, almost doubled, in postmenopausal women 
(Key et al., 2002). Estrogen is a hormone highly crucial for sexual differentiation during prenatal 
development and a primary female sex hormone secreted from the ovaries (Chakraborty et al., 
2012). Early menarche is associated with an increase lifetime exposure to estrogen thereby 
setting the stage for girls earlier on in their lives to heightened risks of breast cancer (Rosenfield, 
Cooke, & Radovick, 2008).  
This relationship between hormones and breast cancer has been established primarily 
through research conducted on women. Few studies have attempted to compare hormone levels 
in girls with and without a family history of breast cancer. The lack of available data on 
hormones in developing girls is a huge oversight. Biro and colleagues (2013) inserted that 
puberty is an important developmental window of vulnerability when rapid growth takes place, 
including expansion and differentiation of breast stem cells. Thus, they propose that during 
preadolescence and adolescence is an ideal opportunity to assess susceptibility and risk for breast 
cancer. The LEGACY Girls Hormone Pilot Study, a study from researchers at the Cancer 
Prevention Institute of California, seeks to fill this gap in literature by gathering preliminary data 
on urinary hormones steroids in developing girls and testing the feasibility of collecting multiple 
urine samplings across menstrual cycles. 
Background 
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In order to better understand the significance of studying hormone concentrations in 
developing girls, the following section will present a review of literature on factors associated 
with breast cancer risks during growth and development including age of menstruation and key 
hormone biomarkers. Furthermore, it will explore the feasibility of a new urine collection tool on 
collecting multiple samples in this specific population, preadolescent and adolescent girls.  
Literature Review 
Pubertal Development and Risk of Breast Cancer 
 Age of Menstruation. Advanced age, family history of cancer in a first-degree relative, 
personal history of BRCA1/BRCA2 mutation, and lifestyle factors including adult weight gain, 
sedentary lifestyle, alcohol consumption are known risk factors for breast cancer in women 
(Stopeck et al., 2014). Early menarche is known to increase women's risk of developing breast 
cancer (Collaborative Group on Hormonal Factors in Breast Cancer, 2012). Precocious puberty, 
which occurs when the pubertal changes occur earlier than expected, when menarche occurs before 
8-9 years of age, also poses various risks. Precocious puberty can also lead to early diagnosis of 
breast cancer and obesity in adults (Biro, 2003). In a cohort of 104,931, there was 20% increase 
risk for women who experience breast development before or at age 10; height, age at menarche, 
and timing between breast development and menarche each independently were associated with a 
20-30% increase in breast cancer risk (Bodicoat et al., 2014). Importantly, the study confirmed that 
time between developmental events is critically important to consider separately from the age of 
attainment (Bodicoat et al., 2014).  Changes in pubertal timing can cause several physical and 
physiological diseases.  
Height, Body Mass Index, and Birth Weight. In addition to early menarche, high birth 
weight, tall childhood stature, and large gains in childhood height and weight have also been 
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associated with increased breast cancer risk (Ahlgren et al., 2004; De Stavola et al., 2004). A 
positive correlation between body mass index and onset of puberty is believed to contribute to the 
trend and to some of the racial/ethnic differences. Girls with a higher body mass index typically 
exhibit earlier onset of puberty. It has been observed that many African-American girls have a 
higher body mass index than Caucasian girls, which can contribute to racial/ethnic differences in 
puberty (Roy et al., 2009).  Roy and colleagues (2009) also found that higher birth weight 
correlated with earlier onset of puberty. The biologic mechanisms underlying associations with 
these indices of growth and development have not been established. These measures may be 
markers of hormones and growth factors that also determine breast ductal growth and 
differentiation, thereby setting the stage for future breast risk. 
The Role of Hormones  
Estrogen, Estradiol Level, and Breast Development.  Breast cancer is a hormone 
responsive disease in part because breast tissue development and differentiation involves several 
hormones. Steroid hormones are produced in the ovary around the time of menarche and declines 
rapidly at around the time of menopause. Estrogen is a hormone secreted from the ovary that plays 
a vital role breast development in girls during puberty and is also involved in the timing of the 
growth spurt in pubertal girls (Chakraborty et al., 2012). In childhood, levels of estrogen estradiol 
are relatively low but again increase rapidly in the year prior to menarche (Rosenfield, Cooke, & 
Radovick, 2008). Breast growth during puberty is also stimulated by increasing estradiol along 
with insulin-like growth factor 1 (IGF-1) stimulated by growth hormone (GH) in the breast tissue. 
Understanding the effects of variations in the levels of concentration on breast tissue development 
and screening for elevated levels of specific hormones can be instrumental in not only contributing 
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to more knowledge about hormone but also targeting early prevention and interventions in at-risk 
groups, those with high concentration of estrogen earlier on in life.  
Ovarian Steroid Hormone Exposures. Known risk factors for breast cancer includes 
ovarian steroid hormone exposure, yet the associations between ovarian hormones such as 
estradiol, progesterone remain unclear (Iversen et al., 2011). Emerging evidence has implicated 
progesterone in the relationship with breast cancer.  In addition to estrogen estradiol secretion in 
the body during pubertal development, progesterone is also highly involved in differentiating 
breast tissue by influencing whether cell proliferate and guard against carcinogenic transformation 
(Lange & Yee, 2008). Few studies have examined the action of progesterone and breast cancer. In 
addition, serum estrogen concentration have been found to be viable clinical marker of exposure to 
estrogen and can be useful tools for assessing a woman’s risk of breast cancer (Clemons et al., 
2009). In conjunction with assessing currently known risk factors such as family history of breast 
and age of menarche, we can provide more accurate assessment of risk in individual women 
through measuring hormone concentrations. 
Urine Collection. Given that the secretion of the ovarian steroid metabolites in the urine 
parallels serum concentrations of the parent hormones, estradiol, and progesterone (De Souza et 
al., 2010), collection of urinary samples serves as a reliable and feasible method of assessing 
ovarian steroids. Findings, however, from studies that do examine hormones have generally been 
inconsistent and based mostly on single samples, making them difficult to interpret (Boffard et 
al., 1981). In order to measure endogenous hormone levels in premenopausal women, some 
studies have opted for a well-established protocol involving measuring creatinine-adjusted 
urinary estrone glucuronide (E1G) and pregnanediol glucuronide (PG) levels in serial early 
morning urine samples on prespecified days of the menstrual cycle (Walker, et al., 2009). This 
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method was shown to be reliable in several studies.  Although ideally, one would want to collect 
daily urine samples to assess variation in ovarian hormone concentrations, such frequent urine 
collection is not feasible in a large-scale study of young girls. Frequent serum sampling is not 
feasible, particularly in young girls (Santoro et al., 2003; Kesner et al., 1992). However, based on 
an analysis of daily urine samples collected by Dr. De Souza from a sample of young adult 
women, it appears that two urine samples per week (Mondays and Thursdays) may be sufficient 
to capture variation in hormones over the course of a menstrual cycle. The LEGACY Girls 
Hormone Pilot Study seeks to study the feasibility of applying a similar protocol. With few 
studies currently available on hormone data from urine samples collected over one or more 
menstrual cycles and many looking at small sample sizes, this pilot will fill the void by gathering 
data to support the planning of a future longitudinal study collecting multiple samples over more 
than one menstrual cycles in a large subset of girls. 
In the present study, participating girls between the ages of 9 to 13 are asked to collect 
multiple first morning urine samples. Post-menarcheal girls, following the first menstrual cycle, 
are asked to collect urine three times a week (Mondays, Wednesdays, and Fridays) while pre-
menarche girls are asked to collect one sample a month for 6 months. Due to large number of 
urine samples, a smaller midstream urine collection tool consisting of an absorbent sponge stripe 
and a slimmer plastic container called a “whizpop” was provided. The “whizpop” was originally 
developed by researchers at Penn State University to handle studies requiring multiple urine 
collections. First morning void were to be collected daily using “whizpops” and urine samples 
were kept frozen by subjects in their home freezers. In the present study, we tested the 
“whizpops’ ease of use, storage compatibility, and ability to measure and capture data on urinary 
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hormone steroids. Figure 1 below shows an image of the “whizpop” and highlights the size 
difference between a “whizpop” (left) and a standard 100ml urine container.    
 
 
Figure 1. Whizpop vs. standard urine container.  
In the next section, a description of the agency will be presented proceeded by an overview of 
the pilot study along with its specific aims and project implementation.  
Description of the Agency/ Project 
 Cancer Prevention Institute of California (CPIC) is a non-profit organization “dedicated 
to preventing cancer and to reducing its burden where it cannot yet be prevented” (CPIC.org). 
CPIC consists of a team of eighteen scientist conducting research to enhance our understanding 
of the causes of cancer, ways to prevent it or detect it early, and to improve outcomes for cancer 
survivor. The organization also participates in cancer surveillance activities through operating 
the Greater Bay Area Cancer Registry. Cancer diagnosis data collected from the nine Bay Area 
counties contribute to cancer statistics on cancer survival and outcomes and helps to guide the 
research conducted at the organization. In addition of the epidemiological research studies and 
surveillance efforts, CPIC is also involved in community development. The Community 
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Education program at CPIC provides resources, including information on workshops and recent 
publications, to cancer patients, their family, and leaders in the medical community.   
The LEGACY Girls Study. Operating within the Research Department at CPIC is the 
LEGACY (Lessons in Epidemiology and Genetics of Adult Cancer from Youth) Girls Study. 
The LEGACY Girls Study multisite study funded by the National Cancer Institute to study girls 
aged 6 to 13 years old and how behavioral, environmental, and dietary factors influence pubertal 
growth and breast cancer risks. This prospective case-control cohort study follows 1040 girls 
from diverse racial and ethnic background and their parent or guardian for five years, with 
follow-ups every 6 months involving components including measurement of height, weight, and 
body composition, a collection of a first morning urine, Tanner staging, and data related to 
growth and development, dietary intake, and lifestyle factors. Approximately half of the girls 
come from families with a history of breast cancer and/or a known genetic mutation related to 
breast cancer risk and half without. The study seeks to gain a better understanding on the 
relationship between early behavioral/lifestyle factors, growth and development, and breast 
cancer risk.  
The LEGACY Girls Hormone Pilot Study. In 2012, a pilot study by the Cancer 
Prevention Institute of California (CPIC) utilized participants from the LEGACY Girls Study to 
study ovarian steroid hormones and other phenotypes related to breast cancer risk (Keegan, 
2010). The pilot study hypothesized that measures of growth and development are associated 
with hormones that influences breast ductal growth and differentiation, thereby setting the stage 
for future breast cancer risk. The small pilot study generated preliminary data and hormone 
assays from 15 post-menarcheal girls. Girls were asked to collect urine samples for 1 menstrual 
cycle and complete a menstrual calendar for 3 months. The present DCRA: LEGACY Girls 
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Hormone Pilot Study expands on the 2012 pilot study changing the urine collection protocol for 
girls from collecting urine samples for 1 menstrual cycle for post-menarche girls to 2 cycles and 
collecting 6-months of urine samples for pre-menarche girls instead of 3. Specific details of the 
LEGACY Hormone Pilot Study are described in the following section.  
Implementation of Project 
Researchers from CPIC now propose to build upon the current infrastructure of the 
LEGACY Girls Study and incorporate the collection of additional urine samples from post-
menarcheal girls to better understand hormone biomarkers including estrogen and progesterone 
metabolites estrone-1-glucuronide (E1G) and pregnanediol-3-glucuronide (PdG), over the 
menstrual cycle. Three investigators, Dr. Esther John and Dr. Theresa Keegan at CPIC, and Dr. 
Whittemore at Stanford are involved in assessing the feasibility of the additional protocol 
component. A Developmental Cancer Research Award (DCRA) was granted to California 
LEGACY site to address the following aims:  
1. Enroll 20 girls who are post-menarche and collect urine samples to assess: 
a. Whether 3 urinary samples per week are sufficient to characterize ovarian 
hormone exposure over a menstrual cycle;  
b. Whether girls are willing to collect samples for 2 cycles. 
2. Enroll 20 pre-menarcheal girls aged 10-13 years and collect one urine sample per 
month for a period of 6 months to assess whether young girls are willing to collect 
urine samples according to this protocol.  
3. Measure urinary estrone-1-glucuronide (E1G) and pregnanediol-3-glucuronide (PdG) 
concentrations in order to:  
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a. Characterize and quantify ovarian steroid exposure, and cycle status in recent 
post-menarcheal girls;  
b. Demonstrate the feasibility of measuring low concentrations of ovarian steroids 
in pre-menarcheal girls and characterize variation and changes of E1G during the 
pubertal transition period; and  
c. Explore differences in exposure to urinary ovarian steroids by race/ethnicity, 
familial BC risk and measures of growth within developmental stage. 
Tracking and Feasibility Analysis. Tracking the study components is highly essential to 
the planning of the R01 study and will help to improve the quality of the study design. In order to 
access the feasibility of the protocol, we tracked the participation rates, adherence to the weekly 
collections of 3 samples for 2 menstrual cycles for post-menarche girls, and adherence to 1 
monthly sample over a 6-month period for pre-menarche girls, willingness to store samples in the 
home freezer, completion rates of specific questionnaire items, and completeness of menstrual 
calendar are carefully monitored. A field interviewer sends weekly correspondence through email 
and texts to daughters to remind them of the collection date and update the urine collection status. 
These updates are noted in an ACCESS database, which also tracks the status of the 
questionnaires. CPIC is an organization that highly values the privacy and confidentiality of study 
participants. Consent and assent forms are IRB approved and must be signed by the participants. 
Each participant and their mothers have a unique and non-identifying ID, which can be used to 
access their online questionnaires via Qualtrics, online data collection software.  
Results 
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 Although the pilot study is still in the data collection phase and results are not available 
yet for the urinary analysis and questionnaire responses, I can still speak to the feasibility of the 
study and basic demographic variables. 
Demographic Variables 
The average age of the girls was 11.1 years. 40% of the girls self-identified as non-
Hispanic White, 17% as Asian-American or Asian, 17% as Hispanic or Latina, and 33% mixed-
race. In the post-menarche group, the average menarche age was 11.75 years.  
Feasibility Measures and Findings 
  The study design for the LEGACY Girls Hormone Pilot Study is simple and was drawn 
from successful studies in the past. It mirrors the existing LEGACY Girls Study in effectively 
tracking the components through an ACCESS database system and utilizes Qualtrics as a 
platform to collect questionnaire data. This makes the study sustainable and feasible since it is 
using already established measures that have been shown to be effective.  
The recruitment goal for the study was 40 girls, 20 girls of pre-menarche status (girls who 
have never had a period) and 20 girls of post-menarche status (girls who have started their 
periods). Pre- and post-menarche status was established through self-reported responses in an 
initial screening call. Initial recruitment efforts yielded 37 girls along with their parent/guardian 
who agreed to participate in the study, which equates to a 92.5% recruitment rate. Of which, 22 
(59.5%) were pre-menarche and 15 (40.5%) were post-menarche status. As the study progressed, 
7 girls (18.9%) decided to no longer participate. As of August 2014, 81.8% (18 out of 22) of the 
pre-menarche girls and 80% (12 of the 15) of post-menarche girls are still actively participating. 
Of these 30 remaining girls, 18 (60%) are pre-menarche and 12 (40%) are post-menarche.  
Based on responses compiled from the exit interview questionnaires completed by 13 
participants and their parent/guardian, we assessed the comprehension of calendar instructions, 
THE LEGACY GIRLS HORMONE PILOT STUDY  14 
 
ease of use of the whizpops. All 13 girls (100%) found the instructions easy to understand and 
the whizpops easy to use. 92.3% of mom also reported that they did not have issues with storage. 
One mom did indicate that she had 2 daughters participating so space was an issue. Responses 
show that the study protocol and materials are appropriate for the age range and is promising in 
using for replication in future studies.  
Public Health Significance 
A better understanding of early-life ovarian steroid exposure and their relationship to 
growth and development indices that are associated with breast cancer risk will help us improve 
our ability to develop and evaluate new breast cancer prevention strategies at a younger age. For 
example, an intervention study to reduce dietary fat intake in girls aged 8-10 years found a 
reduction in serum estradiol and other hormone measures during the follicular phase of the 
menstrual cycle at the year 5-post study visit (Dorgan, Hunsberger, & McMahon, 2008). 
Although follow-up at ages 25-29 years no longer found evidence of lower serum estradiol levels 
in the intervention group (Dorgan et al., 2010). This study nevertheless demonstrates that 
adolescent ovarian steroid levels are modifiable by lifestyle factors during a key period of breast 
development. The current LEGACY Girls Hormone Pilot Study further builds on our knowledge 
of ovarian steroid hormones in addition to highlighting potential differences between pre-
menarche girls and post-menarche girls. By studying the feasibility of such studies, we could 
also expand on the research done on this population. Effective risk assessment tools such as the 
use of whizpop in vulnerable populations can help public health practitioners effectively target 
interventions to yield the greatest impact.  
MPH Competencies Addressed 
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With my interest in cancer prevention and research, my preceptor and I developed six 
goals to be completed throughout the fieldwork experience. Those included: (1) developing 
public health research skills and assisting in the implementation of a pilot study, (2) gaining 
comprehensive understanding of existing literature on the effects of hormones, menstruation, and 
growth and development on breast cancer risks in girls, (3) assisting in the enhancement of study 
protocol for the LEGACY Girls Hormone Study, (4) assisting in modifying materials used to 
perform components of the LEGACY Girls Study, (5) attending professional development and 
research seminars and trainings, and (6) developing basic knowledge of SAS software program 
(language, simple analysis, codes). By carrying out the learning objectives for each of these 
goals, I was able to fulfill the MPH program competencies, four core competencies of public 
health, and four cross-cutting/interdisciplinary competencies.  
For the purpose of my fieldwork, I performed preliminary literature review on the risk of 
breast cancer in developing adolescent girls. I examined potential differences in risk by 
demographic and socioeconomic variables such as race, ethnicity, age, and income as well as 
risk factors such as genetic pre-disposition and family history and environmental exposures. This 
fulfills the first MPH competency, which is the ability to assess, monitor, and review the health 
status of populations and their related determinants of the health and illness. The second 
competency is to demonstrate the ability to utilize the proper statistical and epidemiologic tools 
to assess community needs and program outcomes. My duties for this internship included 
assisting in tracking completion of online questionnaires completed by participants through a 
developed ACCESS database. This data is later pulled and analyzed by Epidemiologist to assess 
variables such as age as well as completion of study components. I also had the opportunity to 
shadow an epidemiologist who compiles data for the LEGACY Girls Study and develop a brief 
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understanding of statistical tools for assessment. For my personal and professional growth in 
statistical programming, I completed a SAS online training course that demonstrates my 
understanding of essentials of statistical analysis and tools.  
The third MPH competency is the ability to identify and prioritize the key dimensions of 
a public health problem by critically assessing public health literature utilizing both quantitative 
and qualitative sources. As noted earlier, I was able to conduct a thorough and comprehensive 
review of literature, which also demonstrates my competency in utilizing online journal 
databases to gather various types of data. I am competent in comprehending measures of risk 
such incidence rates and prevalence rate made available by the CDC and other health 
organizations. Furthermore, my fieldwork experience was especially instrumental in allowing me 
to understand methods for assessing, preventing, and controlling environmental hazards that pose 
risks to human health and safety. This study is testing the feasibility and improving how 
epidemiological research is done on girls, an understudied group. Researchers assessing the use 
of a more appropriate urine collection tool, a “whizpops”, along with its ability to quantify 
hormonal factors associated with increased risk later in life. As apart of my feasibility report, I 
also helped to evaluate best practices and research methods on working with adolescent 
populations in research studies. Findings from this study will help guide interventions or 
prevention strategies in communities that are of greater risks or are disadvantaged. These tools 
allow public health practitioners to better target their audience and make the greatest impacts in 
the most vulnerable communities.  
 Another goal of my fieldwork was to assist in the improvement of the pilot study 
protocol. Thus, I suggested the incorporation of an exit interviewer survey component that will 
be administered at the end of the study. The Program Manager and my preceptor were receptive 
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of the idea and we moved forward with it. I created the questionnaire which aims to evaluate 
how well the study materials were communicated, whether there were issues with urine 
collection, storage compatibility, and whether the families would be interested in further 
participation (See Appendix B.). The responses from the questionnaire will be utilized to 
improve future planning of the study protocol and design for the larger study. I believe this 
demonstrates my ability to articulate the relationship between healthcare delivery, more 
specifically health research delivery and the targeted population. This will also promote sound 
financing (feasibility) because it ensures that there is enough interest in the study for it to be 
viable and the organization is not wastefully allocating funds towards a study with no public 
interest.  
 Another role I took on as an intern was tracking and providing weekly summary report of 
the participating subjects. I was able to apply program planning, management, and evaluation 
skills in doing so. It also allowed me to demonstrate my leadership abilities as a coordinator for 
the project. My preceptor allowed me to be independent and was highly supportive in giving me 
the appropriate level of work including the ability to oversee a field staff and help in 
coordinating the home visits and collecting study components. In addition, I attended monthly 
meetings between the coordinator and researchers and I was not hesitant to offer my ideas and 
suggestions to improve the study protocol. I also took some time to review the IRB approved 
consent forms for moms and assent forms for daughters ensuring that they are aware of potential 
risks. It is important in public health not only to obtain data but also protecting the safety of 
participants in the studies. Therefore, for the LEGACY Girls Hormone Pilot Study, I ensured 
that the consent and assent forms were collected prior to participation to the study. In the 
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feasibility report, I also made suggestions to the hormone pilot study protocol to address 
potential cultural barriers to participating in the study and to help enhance the quality of the data.  
 With the approval of my preceptor, I also participated in the Minority Training Program 
in Cancer Control Research (MTPCCR) program as part of a professional and leadership 
development goal in my learning contract. This program aims to increase understanding of the 
power of research to effect change, promote awareness of the strengths and limitations of 
research methods, theory, and interventions in eliminating health disparities, and develop 
participant’s interest in cancer control research, from surveillance to epidemiology, individual 
behavior change, health services, and policy research. This enriching program gave me the 
opportunity to network with current researchers from various fields. I developed a greater 
understanding of the interdisciplinary nature of public health and how collaborating with 
different experts in the field can be beneficial in conducting innovative and applicable research 
studies. This training also touches on cross-cutting competencies of public health tied to diversity 
and culture. MTPCCR believes in the concept of being an “insider” researcher, which sees our 
culture as our strength. Because we identify with that population or group, we are more aware of 
the barriers and issues and thus can better cater our research to eliminating health disparities 
particularly in minority and at-risk populations.  
 My fieldwork experience touched on four of the core knowledge areas: epidemiology, 
social and behavioral sciences, environmental health, and public health administration and 
leadership. As an intern of the LEGACY Hormone Pilot Study, I assisted in the tracking and 
performing quality control of collected data, which helps to better assess the risk of the 
population and factors affecting the population. These tasks relates to the field of epidemiology, 
which examine the causes of health problems and risk factors in the population. For social and 
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behavioral science, I conducted literature review of social and cultural factors present in the 
Hormone Pilot Study that consider differences in breast cancer risk and breast cancer risk factors 
by family history, age, ethnicity and race. Literature suggest that African American women are 
disadvantage due to their higher exposure to chemicals, higher mortality rates even though their 
overall incidence rate are lower than white women. It is also found that factors like quality of 
health care, later follow-ups after a mammogram, and their risks of developing more aggressive 
triple-negative breast cancer are reasons for their higher mortality rates. Assessing cultural 
barriers in this population as well as policies may improve their health outcome. In addition, 
through developing the exit interview questionnaire, it opens up the conversation between the 
researchers and participants on more effective ways to carry out the study and assess barriers 
they may face.  
Along with epidemiology, environmental health is the next relevant core knowledge area 
addressed in my fieldwork. Harmful exposures to environmental hazards such as chemicals are 
risk factors for early menarche, which indirectly affects early exposure to hormones such as 
estrogen. Epidemiological studies like the LEGACY Girls Hormone Pilot Study is highly 
significant in guiding prevention strategies to decrease exposure to excess environmental hazards 
as high-level of estrogen in later life for women increases their chances of development breast 
cancer. It is now more inherent to me the value accessing hormone levels and promoting 
modification of diet and/or physical activity to reduce the level of exposure in at-risk groups.  
Last, I believe my experience also contributed to my public health administration and 
leadership skills. Through examining the works of local groups such as a the Breast Cancer Fund 
and the Environmental Working Group, I have learned about ways researchers and individuals 
are combatting the environmental issues associated with breast cancer. This pilot study, though 
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small in scope, has the potential to inform best practices and methods to reach broader 
populations. I see the prospective of improving the quality of involvement from the community 
and how findings from the study can also inform the public about early prevention strategies. It 
can also inform policy to address issues of early hormone exposure caused by obesity, endocrine 
disrupting chemicals, and environmental stressors. More epidemiological longitudinal research 
must be done to elucidate the nature of early pubertal onsets including the associated hormones 
and breast cancer development later in life.  Appendix A. shows the full Learning Contract with 
detailed descriptions of the goals and associated learning objectives can be found  
The competencies listed above were completed with the knowledge acquired through my 
graduate education from USF and the MPH program. Biostatistics, epidemiology, environmental 
health, and Advanced Epidemiology with Statistical Software Application were especially 
relevant courses in preparing me to carry out my activities at my fieldwork.  
Conclusion 
From conducting the review of literature on this topic, I realized that breast cancer 
etiology is complex and there continues to be significant gaps in our knowledge on the 
development of this disease. These gaps in knowledge impede our ability to prevent breast 
cancer and reduce its high morbidity and mortality rates. The strongest risk factors we know for 
breast cancer so far are being female and having a family history of breast cancer. Whether the 
increased risk manifests early in life and whether alterations in steroid hormone levels may be 
one of these manifestations is still unknown. Studies like this one will not only shed light on 
early mechanisms in breast cancer etiology, but will also contribute to better understanding the 
potential of steroid hormones as risk markers and inform prevention efforts geared at reducing 
breast cancer risk.  
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Overall, the fieldwork was a great introduction for me into the field of epidemiology. It 
allowed me to actively take part in the implementation of a research study and allowed me to 
understand an issue that I had little prior knowledge about. I learned that in addition to acquiring 
an understanding on what the literature has to say about the issue, it is equally important to know 
how the studies are carrying it out. Understanding the methodology and protocol employed helps 
us to evaluate how valid and reliable the data really is and whether it is answering the intended 
research question. Personally, I feel like I’ve grown a lot through the experience, especially in 
my ability to be flexible and to think on my feet. It is especially important to have these skills 
with working on pilot studies, which are prone to changes along the way. My preceptor was 
helpful and open to allowing me to work independently. She was very receptive of my 
suggestions and allowed me to take initiative on key parts of the study. Through the experience, I 
was able to gain more confidence in my ability to contribute in public health especially in the 
realm of research. As a future public health practitioner, I am optimistic that more studies like 
the LEGACY Girls Hormone Pilot Study will continue to provide valuable information on ways 
to combat preventable diseases.  
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Masters in Public Health  
Fieldwork Form: Student Preceptor Agreement  
 
 
Master of Public Health Program 
 
MPH PROGRAM COMPETENCY INVENTORY – Attachment 2 USF 
 
MPH Competencies  Proposed Activities  Number of Hours (Estimated)  
1. Assess, monitor, and review the health 
status of populations and their related 
determinants of health and illness.  
Perform a literature review on the risk of breast cancer in a special 
population, adolescent girls. 
 
Examine possible differences by demographic and socioeconomic variables 
such as race, ethnicity, age, income as well as other risk factors such as 
genetic pre-disposition/family history and environmental exposure.  
 
Determine the possible gaps in literatures. 
25 
2. Demonstrate the ability to utilize the 
proper statistical and epidemiologic tools 
to assess community needs and program 
outcomes.  
Compile statistics that confirms the need to address the population 
researched (ex. girls, genetics/family history, SES, growth and development 
factors). 
15 
3. Identify and prioritize the key dimensions 
of a public health problem by critically 
assessing public health literature utilizing 
both quantitative and qualitative sources.  
Conduct a comprehensive review of literature on biomarkers such as 
hormones related to growth and development in adolescent girls that may be 
are linked to risks of breast cancer later in life.    
 
Determine how hormone biomarker information collected from urine 
samples can provide insight on early-life factors that may influence health 
later in life.   
30 
4. Specify approaches for assessing, 
preventing, and controlling environmental 
hazards that pose risks to human health 
and safety.  
Further examine existing literature on the use and/or proposed use of 
“whizpops”	  in	 study	 to	 assess	 the	  risk	 of	 younger	 participants.	  
 
Evaluate best practices and research methods with working with adolescent 
populations in research studies. 
10 
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Masters in Public Health  
Fieldwork Form: Student Preceptor Agreement  
 
 
5. Apply theoretical constructs of social 
change, health behavior and social justice 
in planning community interventions.  
Synthesize the issues experienced during the pilot study and provide 
strategies to enhance protocol. 
20 
6. Articulate the relationship between health 
care delivery and financing, public health 
systems, and public policy.  
Shadow study interviewer on a home visit with the participant. 
 
5 
7. Apply evidence-based principles to the 
process of program planning, 
development, budgeting, management, and 
evaluation in public health organizations 
and initiatives.  
Evaluate the feasibility of the pilot hormone study.  
 
Summarize findings that may contribute to the development of future grant 
proposals. 
15 
8. Demonstrate leadership abilities as 
collaborators and coordinators of evidence 
based public health projects.  
*Attend meetings between coordinators, researchers, and epidemiologist. 8 
9. Identify and apply ethical, moral, and legal 
principles in all aspects of public health 
practice.  
Address legal and ethical concerns of the Pilot Hormone Study, including 
human-subjects protections, etc. 
5 
10. Develop public health programs and 
strategies responsive to the diverse 
cultural values and traditions of the 
communities being served.  
Present a report on possible modification or suggestions to the hormone pilot 
study protocol to address barriers to participating in the study and to help 
enhance the quality of the data.   
25 
11. Effectively communicate public health 
messages to a variety of audiences from 
professionals to the general public.  
  
12. Advance the mission and core values of the 
University of San Francisco.  
  
CEPH Core Knowledge Areas  Proposed Activities  Number of Hours (Estimated)  
Biostatistics    
Epidemiology   Assess the risk and compile statistics that confirms the need to address the 40  
 
Masters in Public Health  
Fieldwork Form: Student Preceptor Agreement  
 
 
population researched (ex. girls, genetics/family history, SES, growth and 
development factors). 
Social and Behavioral Sciences  Address social and cultural factors present in the Hormone Pilot Study  50  
Environmental Health    
Public Health Administration and 
Leadership  
Develop best method of reaching populations in the Bay Area, in regard to 
study participation, quality of involvement, cost, etc.  
25 
Cross-  
Cutting/Interdisciplinary Values  
Proposed Activities  Number of Hours (Estimated)  
Communication and Informatics  Collect necessary information and provide suggestion for improvement for 
future grant proposal; attend meetings and report on the weekly progress of 
participants during the study   
60 
Diversity and Culture  Attend the MTPCCR Program: Helps to develop awareness of the strengths 
and limitations of research methods, theory, and interventions in eliminating 
health disparities particularly in minority and at-risk populations.  
 
40 
Leadership    
Professionalism  Attend the MTPCCR Program: Helps to develop research, networking, 
information seeking skills, and motivation and ability to successfully apply to 
a doctoral program. 
40 
Program Planning    
Public Health Biology    
Systems Thinking  Take into account various roles of  LEGACY Girls Hormone Study staffs, 
researchers, coordinators, and community members to establish effective 
recruitment methods, implementation of protocol, and fulfill our research 
capacity  
50  
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Appendix B.  DCRA: Pre/Post Exit Interview Survey  
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     LEGACY GIRLS Hormone Pilot Study: Exit Interview Form 
Questions for participating girls: 
1.Did you have any problems filling out the calendars? 
 
Please explain: 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
2. Were the instructions easy to understand?  
Please explain: 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
3. Did you miss any days?  
 
4. Did you have any problems with completing the collection of the urine? 
 
 
5. Please answer the following questions: Circle Yes or No 
Were the ‘whizpops’ easy to use?   Yes       No 
Was the sample box easy to use?  Yes       No 
Was it difficult to write the date and time on the whizpops? Yes       No 
Was storage of the samples in your freezer ok? Yes       No 
Was it difficult for you to collect 3 samples a week? Yes       No 
 
6. Would you be willing to participate in this study for another 2 years?  
 
Yes______!No______!
Yes______!No______!
Yes______!No______!
Yes______!No______!
Yes______!No______!
!
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Questions for moms of participating girls: 
1.  Did you have any issues storing the samples in your freezer?  
  
 
2. Would you be willing to participate in this study for another 2 years?  
 
 
If no, why? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________  
3. Would you be comfortable with your daughter(s) providing other biospecimen 
such as blood or saliva samples? (Blood sample once a year and saliva 
samples every 6 months). 
 
 
If no, why? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________  
4. Are you willing to travel to our office in Fremont for a visit once a year? Travel 
expenses will be covered.   
 
 
5. Please provide any additional feedbacks or comments below. 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_____________________________________ ____________________________________
_________________________________________________________________________  
Thank you.  
Yes______!No______!
Yes______!No______!
Yes______!No______!
Yes______!No______!
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     LEGACY GIRLS Hormone Pilot Study: Exit Interview Form 
Questions for participating girls: 
1.Did you have any problems filling out the calendars? 
 
Please explain: 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
2. Were the instructions easy to understand?  
Please explain: 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
3. Did you miss any days? 
 
4. Did you have any problems with completing the collection of the urine? 
 
 
5. Please answer the following questions: Circle Yes or No 
Were the ‘whizpops’ easy to use?   Yes       No 
Was the storage box easy to use?  Yes       No 
Was it difficult to write the date and time on the whizpops? Yes       No 
Was storage of the samples in your freezer ok? Yes       No 
Was it difficult for you to collect 1 sample, once a month? Yes       No 
 
6. Would you be willing to participate in this study for another 2 years?  
 
Yes______%No______%
Yes______%No______%
Yes______%No______%
Yes______%No______%
Yes______%No______%
PRE - Revised 6.10.14 
 
 
Questions for moms of participating girls: 
1.  Did you have any issues storing the samples in your freezer?  
  
 
2. Would you be willing to participate in this study for another 2 years?  
 
 
If no, why? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________  
3. Would you be comfortable with your daughter(s) providing other biospecimen 
samples such as a saliva sample, once every 6 months?  
If no, why? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________  
4. Are you willing to travel to our office in Fremont for a visit once a year? Travel 
expenses will be covered.   
 
 
5. Please provide any additional feedbacks or comments below. 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_____________________________________ ____________________________________
_________________________________________________________________________  
Thank you.  
Yes______%No______%
Yes______%No______%
Yes______%No______%
